Try our mobile app

Switch to company model in classical logic    *

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2...
Website: floragrowth.com




Profitability: LTM EBITDA margin is negative, -300.0%. Gross margin is normal, +38.4%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.71 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.0% (LTM)

Entry Point: Share price is 894.4% higher than minimum and 89.6% lower than maximum for the last 3 years

Insiders: For the last 3 months insiders bought company shares on $1.0 mln (0.396% of cap.)

Key Financials (Download financials)

Ticker: FLGC
Share price, USD:  (-1.6%)1.79
year average price 1.5077  


year start price 0.2251 2023-04-20

min close price 0.1800 2023-05-03

max close price 3.9100 2023-06-09

current price 1.7900 2024-04-18
Common stocks: 132 868 000

Dividend Yield:  0.0%
Last revenue growth (y/y):  ---
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  0.0%
Historical growth of EBITDA:  0.0%
EV / Sales: 55.0x
Margin (EBITDA LTM / Revenue): -300.0%
Fundamental value created in LTM:
Market Cap ($m): 238
Net Debt ($m): -18
EV (Enterprise Value): 220
Price to Book: 37.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2023-11-16InvestorPlace

Why Is Flora Growth (FLGC) Stock Up 7% Today?

2023-08-26MarijuanaStocks

Late August Green: Top Penny Stocks for the Last Week of August

2023-08-20MarijuanaStocks

Marijuana Penny Stocks on the Radar
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31
symbol FLGC FLGC FLGC FLGC FLGC FLGC FLGC
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-03-28 2023-11-08 2023-08-10 2023-05-15 2023-03-31 2022-09-30 2021-12-31
acceptedDate 2024-03-28 16:44:47 2023-11-08 16:01:53 2023-08-10 16:01:55 2023-05-15 16:25:58 2023-03-30 20:00:00 2022-09-30 00:00:00 2021-12-31 00:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2021.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q4
revenue 18M 17M 21M 20M 11M 11M 5M
costOfRevenue 18M 12M 18M 15M 9M 6M 4M
grossProfit 406 000 5M 4M 5M 3M 5M 794 000
grossProfitRatio 0.023 0.285 0.185 0.272 0.252 0.462 0.166
researchAndDevelopmentExpenses 25 000 8000.000 13 000 16 000 -162 000 170 000 67 000
generalAndAdministrativeExpenses 5M 3M 6M 6M 7M 5M 9M
sellingAndMarketingExpenses 997 000 1M 1M 1M 2M 2M 0
sellingGeneralAndAdministrativeExpenses 3M 5M 7M 7M 8M 8M 8M
otherExpenses 0 0 0 2M 1M 2M 2M
operatingExpenses 3M 5M 9M 9M 9M 9M 10M
costAndExpenses 21M 18M 27M 23M 18M 15M 14M
interestIncome 0 16 000 28 000 0 0 0 0
interestExpense 25 000 16 000 28 000 23 000 33M 75 000 -37 000
depreciationAndAmortization 292 000 306 000 944 000 942 000 -68 000 985 000 579 000
ebitda -2M -248 000 -4M -2M 22M -3M -12M
ebitdaratio -0.133 -0.014 -0.194 -0.105 1.942 -0.315 -2.537
operatingIncome -3M -540 000 -40M -3M 22M -4M -10M
operatingIncomeRatio -0.150 -0.031 -1.867 -0.152 1.948 -0.407 -2.136
totalOtherIncomeExpensesNet -5M 1M -33M -923 000 -36M -3M -4M
incomeBeforeTax -8M 579 000 -38M -4M -14M -7M -13M
incomeBeforeTaxRatio -0.417 0.033 -1.776 -0.197 -1.224 -0.686 -2.661
incomeTaxExpense -381 000 -51 000 -1M -66 000 -2M -30 000 -98 000
netIncome -8M 1M -45M -4M -13M -7M -13M
netIncomeRatio -0.461 0.071 -2.076 -0.194 -1.090 -0.684 -2.630
eps -0.930 0.092 -6.660 -0.029 -0.300 -0.096 0
epsdiluted -0.930 0.084 -6.620 -0.029 -0.300 -0.096 0
weightedAverageShsOut 9M 7M 7M 133M 42M 77M 0
weightedAverageShsOutDil 9M 8M 7M 133M 42M 77M 0
link Link Link Link Link Link
finalLink Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol FLGC FLGC FLGC FLGC FLGC FLGC FLGC
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-03-28 2023-11-08 2023-08-10 2023-05-15 2023-03-31 2022-09-30 2022-06-30
acceptedDate 2024-03-28 16:44:47 2023-11-08 16:01:53 2023-08-10 16:01:55 2023-05-15 16:25:58 2023-03-31 16:16:41 2022-09-30 00:00:00 2022-06-30 00:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 4M 5M 2M 5M 10M 6M 10M
shortTermInvestments 0 0 0 0 -729 270 0 0
cashAndShortTermInvestments 4M 5M 2M 5M 10M 6M 10M
netReceivables 7M 7M 8M 10M 11M 5M 5M
inventory 9M 11M 9M 10M 10M 10M 9M
otherCurrentAssets 1M 957 000 2M 2M 978 000 2M 2M
totalCurrentAssets 21M 24M 22M 28M 31M 23M 27M
propertyPlantEquipmentNet 1M 2M 2M 7M 7M 8M 8M
goodwill 0 0 0 23M 23M 29M 29M
intangibleAssets 946 000 5M 6M 17M 18M 13M 13M
goodwillAndIntangibleAssets 946 000 5M 6M 41M 41M 42M 42M
longTermInvestments 0 200 000 200 000 730 000 730 000 755 000 1M
taxAssets 0 0 0 0 0 0 0
otherNonCurrentAssets 80 000 285 000 263 000 276 000 287 000 355 000 273 000
totalNonCurrentAssets 2M 8M 8M 49M 50M 50M 52M
otherAssets 0 0 0 0 -2000.000 0 0
totalAssets 24M 32M 30M 77M 81M 73M 79M
accountPayables 5M 7M 7M 6M 8M 8M 7M
shortTermDebt 3M 2M 2M 2M 2M 1M 1M
taxPayables 0 0 0 0 0 0 0
deferredRevenue 0 2M 3M 0 0 0 0
otherCurrentLiabilities 8M 6M 6M 7M 7M 18 000 20 000
totalCurrentLiabilities 16M 17M 18M 15M 17M 9M 9M
longTermDebt 942 000 1M 1M 2M 2M 2M 3M
deferredRevenueNonCurrent 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 481 000 523 000 2M 2M 2M 2M
otherNonCurrentLiabilities 0 385 000 848 000 5M 4M 2M 4M
totalNonCurrentLiabilities 942 000 2M 2M 8M 7M 10M 8M
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 942 000 2M 2M 3M 3M 3M 4M
totalLiabilities 17M 18M 20M 23M 25M 19M 17M
preferredStock 0 0 0 0 0 0 0
commonStock 0 0 0 0 0 120M 119M
retainedEarnings -143M -134M -138M -94M -91M -78M -72M
accumulatedOtherComprehensiveIncomeLoss -140 000 -2M -2M -2M -3M -3M -2M
othertotalStockholdersEquity 149M 150M 151M 150M 150M 16M 17M
totalStockholdersEquity 6M 14M 11M 54M 57M 54M 63M
totalEquity 6M 13M 10M 54M 57M 54M 63M
totalLiabilitiesAndStockholdersEquity 24M 32M 30M 77M 81M 73M 79M
minorityInterest 0 -1M -706 000 -440 000 -411 000 0 0
totalLiabilitiesAndTotalEquity 24M 32M 30M 77M 81M 73M 79M
totalInvestments 0 200 000 200 000 730 000 730.000 755 000 0
totalDebt 4M 3M 3M 4M 4M 3M 4M
netDebt -713 000 -2M 2M -1M -5M -3M -7M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2021 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2021-09-30
symbol FLGC FLGC FLGC FLGC FLGC FLGC FLGC FLGC
reportedCurrency USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-03-28 2023-11-08 2023-08-10 2023-05-15 2022-12-31 2022-09-30 2021-12-31 2021-09-30
acceptedDate 2024-03-28 16:44:47 2023-11-08 16:01:53 2023-08-10 16:01:55 2023-05-15 16:25:58 2022-12-31 00:00:00 2022-09-30 00:00:00 2021-12-31 00:00:00 2021-09-30
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2021.000 2021.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q4 Q3
netIncome -8M 1M -45M -4M -13M -7M -13M -4M
depreciationAndAmortization 292 000 306 000 944 000 942 000 -68 000 985 000 579 000 67 000
deferredIncomeTax 1M -51 000 -1M -66 000 -2M 0 -98 000 0
stockBasedCompensation 595 000 4000.000 338 000 654 000 220 000 140 000 852 000 393 000
changeInWorkingCapital 616 305 -926 000 3M -3M 4M 191 000 6M -10M
accountsReceivables -388 717 740 871 1M 0 0 0 0 0
inventory 2M -2M 1M -113 000 2M -185 000 -116 000 -604 000
accountsPayables -923 982 98 418 425 740 0 0 0 0 0
otherWorkingCapital -201 314 719 711 -14 811 113 000 2M 376 000 0 0
otherNonCashItems 4M 63 000 38M 912 000 8M 3M 0 3000.000
netCashProvidedByOperatingActivities -1M 518 000 -3M -4M -2M -3M -1M -14M
investmentsInPropertyPlantAndEquipment 40 320 -6000.000 -93 000 -102 000 -346 000 -226 000 -3M -88 000
acquisitionsNet 941.094 -71 298 0 0 880 000 69 000 -7M 0
purchasesOfInvestments 0 0 0 0 79 000 0 1M -1M
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0
otherInvestingActivites -0.094 298.000 0 0 -79 000 0 73 000 29 000
netCashUsedForInvestingActivites 41 261 -77 000 -93 000 -102 000 534 000 -157 000 -8M -1M
debtRepayment -763 532 -54 000 -58 000 -19 000 -511 000 -287 000 -171 000 -63 000
commonStockIssued -62 032 -313 323 -17 060 0 5M 0 25M 1M
commonStockRepurchased 0 0 0 0 -250 000 -5000.000 0 0
dividendsPaid 0 0 0 0 0 0 0 0
otherFinancingActivites -36 291 3M 206 060 0 2M -123 000 8M 10M
netCashUsedProvidedByFinancingActivities 665 207 2M 131 000 -19 000 5M -415 000 32M 11M
effectOfForexChangesOnCash -24 000 370 000 417 000 167 000 -140 000 -447 000 -204 000 -418 000
netChangeInCash -413 000 3M -3M -4M 4M -4M 23M -4M
cashAtEndOfPeriod 4M 5M 2M 5M 10M 6M 38M 15M
cashAtBeginningOfPeriod 5M 2M 5M 10M 6M 10M 15M 19M
operatingCashFlow -1M 518 000 -3M -4M -2M -3M -1M -14M
capitalExpenditure 40 320 -6000.000 -93 000 -102 000 -346 000 -226 000 -3M -88 000
freeCashFlow -984 148 512 000 -4M -4M -2M -4M -4M -14M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2023 q2
2023-08-15 ET (fiscal 2023 q2)
2023 q1
2023-04-03 ET (fiscal 2022 q4)
2022 q3
2022-11-28 ET (fiscal 2022 q3)
2022 q2
2022-08-15 ET (fiscal 2022 q2)

Press-releases

Show financial reports only

2024-02-05 18:03 ET
Flora Growth Corp's CEO Reveals Record-Breaking Financials and Exciting 2024 Plans
2024-01-22 14:15 ET
Flora Growth Corp. To Chair U.S. Hemp Roundtable Board of Directors
2023-11-08 21:05 ET
Flora Growth Corp. Reports Record Q3 2023 with Net Income of $1.1 Million and EBITDA of $0.9 Million
2023-10-25 02:44 ET
Lifeist Terminates Agreement for Sale of Australian Vapes
2023-10-16 20:01 ET
Flora Growth Corp. Announces Resignation of Director
2023-10-02 20:01 ET
Flora Growth Corp. Announces Transition of Hussein Rakine from Director to Special Advisor
2023-09-19 12:00 ET
Flora Growth Corp. Announces Pricing of $2.7 Million Registered Direct Offering and Concurrent Private Placement
2023-09-18 11:00 ET
Lifeist Announces Sale of Non-core Subsidiary Australian Vapes
2023-09-18 10:05 ET
Flora Growth Corp. to Acquire Australian Vaporizers; Expects Immediate Profit Contribution
2023-08-17 20:30 ET
Flora Growth Corp. and TruHC Pharma GmbH Establish Strategic Partnership to Grow Market Share in Germany
2023-08-10 20:01 ET
Flora Growth Corp. Reports Second Quarter 2023 Financial Results
2023-08-01 20:01 ET
Flora Growth Corp. Announces an Exclusive Worldwide Partnership with Legendary Superstar Hulk Hogan
2023-07-25 20:30 ET
Flora Growth Corp. Announces Update on Sale of Colombian Assets; Expects Asset Sale to Contribute to Anticipated Annual Savings of US$6.1 million
2023-06-27 20:05 ET
Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement
2023-06-07 20:05 ET
Flora Growth Corp. to Effect Reverse Stock Split
2023-05-24 20:57 ET
Flora Growth Corp. Announces Change to Location of Annual and Special Meeting
2023-05-15 20:05 ET
Flora Growth Reports First Quarter 2023 Financial Results
2023-04-18 20:05 ET
Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors
2023-04-04 11:05 ET
Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in Colombia
2023-03-31 20:05 ET
Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year
2023-03-21 11:05 ET
Flora Growth to Announce 2022 Year End Results April 3, 2023, at 8:00 a.m. ET
2023-02-21 12:05 ET
Flora Growth Begins Product Sales in Juan Valdez, Colombia’s Largest Coffeehouse Chain
2023-01-30 12:05 ET
Flora Growth Issues 2023 Revenue Guidance of $90 Million to $105 Million Reflecting Anticipated Year Over Year Growth Exceeding 100%
2023-01-26 12:05 ET
Flora Growth to Host 2022 Year End Review Webcast January 30, 2023
2023-01-06 21:05 ET
Flora Growth Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
2023-01-05 12:05 ET
Flora Growth Provides Update to International Commercial Cannabis Export Business
2022-12-27 12:05 ET
Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and the European Union
2022-12-23 23:18 ET
Franchise Global Health Inc. Completes Plan of Arrangement with Flora Growth Corp.
2022-12-09 13:30 ET
Flora Growth Corp. Announces Pricing of $5.0 Million Registered Direct Offering
2022-11-30 14:30 ET
New York Issues First 36 Licences for Recreational Cannabis Dispensaries
2022-11-28 12:05 ET
Flora Growth Reports Third Quarter 2022 Financial Results
2022-11-21 12:05 ET
Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET
2022-11-16 13:39 ET
Flora Growth Completes Construction of Laboratory, Specializing in Prescription Cannabis Formulations
2022-11-10 13:00 ET
Flora Growth Announces Shareholders Owning Over 73% of Shares of Franchise Global Health Support Acquisition by Flora
2022-10-25 11:05 ET
Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022
2022-10-24 11:30 ET
Flora Growth Signs Definitive Agreement to Acquire Franchise Global Health, a Prominent Pharmaceutical and Medical Cannabis Distributor with Principal Operations in Germany
2022-09-26 11:05 ET
Flora Growth Completes Multiple Commercial Cannabis Exports Into New International Markets
2022-09-13 11:05 ET
Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference
2022-09-07 11:05 ET
Flora Growth Acquires No Cap Hemp Co., Bolstering Product Offering And Revenue Streams
2022-08-15 20:00 ET
Flora Growth Reports H1 2022 Financial Results
2022-08-10 11:05 ET
Flora Growth Sets First Half 2022 Conference Call for August 15, 2022, at 4:30 p.m. ET
2022-08-02 11:05 ET
Flora Growth Announces Joint Venture with Colombia’s Largest Indigenous Tribe to Process and Distribute Cannabis Products
2022-07-22 11:05 ET
Flora Growth CEO Meets With Colombian Senator as Bill to Legalize Recreational Cannabis Is Introduced
2022-07-11 11:05 ET
Flora Growth Taps Amazon Executive Elshad Garayev As Chief Financial Officer
2022-07-06 11:05 ET
Flora Growth Announces Results of Annual Meeting of Shareholders; Appointment of Brandon Konigsberg to Board of Directors
2022-06-21 11:05 ET
Flora Growth Congratulates Colombia’s Pro-Cannabis President-Elect
2022-06-16 11:05 ET
Flora Growth Corp. Announces $5 Million Share Repurchase Program
2022-05-31 11:05 ET
Flora Growth Launches JustCBD on Amazon UK
2022-05-23 11:05 ET
Flora Growth Acquires CBD Brand Masaya
2022-05-18 11:05 ET
Flora Growth’s Vessel Brand Launches Collaboration With Ricky Williams’ Cannabis Brand Highsman
2022-05-17 20:15 ET
Flora Growth to Host Regulatory Webinar Prior to Holly Bell Speaking Engagement at Florida Hemp Conference
2022-05-16 11:05 ET
Flora Growth Appoints Cannabis Regulatory Veteran Holly Bell as Vice President of Regulatory Affairs
2022-05-12 11:05 ET
Flora Growth Establishes On-the-Ground Presence in UK and EU
2022-05-11 14:28 ET
Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca
2022-05-10 11:00 ET
Flora Growth Reports Fiscal Year End 2021 Results
2022-05-06 11:05 ET
Flora Growth to Report Fiscal Year 2021 Results on May 10; Schedules Webcast
2022-05-04 11:05 ET
Flora Growth’s MIND Naturals Launches New Skincare Line Ahead of Luxury Brand Conference in NYC
2022-04-29 11:05 ET
Flora Growth CEO, CSO Featured Speakers at Luxury Meets Cannabis Conference in New York
2022-04-28 11:05 ET
Flora Growth Streamlines Its Global Supply Chain With First-Ever Sourcing of Company’s CBD Into Market-Ready Products
2022-04-12 13:05 ET
Flora Growth Chairman and CEO Luis Merchan To Speak At Leading Cannabis Event In Miami: Benzinga Cannabis Capital Conference, April 20-21, Fontainebleau Hotel
2022-04-07 11:05 ET
Flora Growth’s Newly Acquired, JustCBD, Signs Deal with Distribution Giant OTG Management to Sell CBD Products in Airports
2022-04-05 11:05 ET
Flora Growth’s Newly Acquired JustBrands Appointed to Board of Directors at the US Hemp Roundtable
2022-04-04 11:05 ET
Flora Growth Recognizes Colombia’s Completion of Cannabis Flower Export Rules, Prepares First Export Under New Regulations
2022-03-30 11:05 ET
Flora Growth CEO to Deliver Keynote Address at Plant Medicine Week Conference in Malta
2022-03-23 11:05 ET
Flora Growth to Expand Physical Presence in Europe Through JustCBD Partnership with Greenyard
2022-03-17 12:00 ET
Flora Growth Appoints Former Amazon Executive Tim Leslie to Its Board of Directors and Names CEO Luis Merchan Chairman
2022-03-15 11:05 ET
Flora Growth Receives 2022 Export Quota for 43,600kg of High THC Cannabis
2022-03-14 11:05 ET
Flora Growth Signs Agreement to Distribute Mind Naturals in the Hong Kong Region
2022-03-04 13:30 ET
Flora Growth Corp. (NASDAQ: FLGC) Breaks Out of M&A Gate in 2022
2022-03-04 12:30 ET
Flora Completes Inaugural U.S. Import of CBD Food & Beverage Products from Colombia; Validates New Low-Cost Supply Chain Pathway
2022-03-02 13:30 ET
Flora Growth Corp. (NASDAQ: FLGC) Strengthens Position with Significant Acquisition
2022-03-02 12:45 ET
Flora’s Consumer Technology Brand, Vessel, Signs Distribution Agreement with JustCBD Partner Speedy
2022-02-28 12:45 ET
Flora Growth Completes Acquisition of Category Leading Wellness Brand JustCBD; Enhances U.S. Infrastructure and CPG Portfolio
2022-02-25 12:05 ET
Flora Growth Appoints Jessie Casner As Chief Marketing Officer to Drive Growth of Brand Portfolio
2022-02-22 12:05 ET
Flora Growth Registers First-Ever Cannabinoid Food and Beverage Products with Colombian-FDA
2022-02-16 12:05 ET
Flora Growth Signs Agreement with Artos Ltd. to Send High-THC Cannabis Flower to Israel
2022-02-11 12:05 ET
Flora to Host CBD and the Global Market Webinar Today
2022-02-08 12:05 ET
Flora Growth Names Vessel Founder, James Choe, Chief Strategy Officer
2022-02-02 12:05 ET
Flora Growth Announces Patent-Pending Cannabinoid-Based Product, Seeks INVIMA (Colombian FDA) Emergency Use Authorization Under COVID-19 Protocols
2022-01-27 12:05 ET
Flora Growth Appoints Award-Winning Operations Expert Joël Reyes as SVP of Global Operations
2022-01-24 12:05 ET
Flora Growth Appoints Industry-Leading Cultivator Derek Pedro as Genetics and Cultivation Advisor
2022-01-11 12:05 ET
Flora Growth Completes Successful First Cannabis Extraction Through New Facility, Initiates EU-GMP Certification Process
2022-01-06 12:05 ET
Flora Growth Appoints Industry Authority Tim Leslie as Chairman of Its Newly Formed Advisory Board
2022-01-04 13:17 ET
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Luis Merchan, CEO of Flora Growth Corp.
2022-01-04 12:05 ET
Flora Growth Expands Product Distribution Through Walmart.com and Coppel in Mexico
2021-12-14 12:05 ET
Flora Growth to Host Year End Review Webinar Today
2021-12-09 12:05 ET
Flora Growth’s Vessel Brand Division Expands Into Dry Herb Market with New Devices and Accessories
2021-12-06 12:05 ET
Flora Growth Provides 2022 Revenue Guidance of US$35-45 Million; Sets Date for Year End Review Webinar
2021-12-02 12:25 ET
Flora Growth Continues International Expansion with Initial Exports to Mexico and Spain
2021-11-29 12:05 ET
Flora Growth Enters Cannabis Beverage Market Through Licensing Agreement with Tonino Lamborghini
2021-11-26 12:05 ET
Flora Growth Forms JV With Avaria Health and Beauty to Distribute Award-Winning Pain Products Across LATAM
2021-11-23 22:00 ET
Flora Growth Closes $34.5 Million Public Offering
2021-11-19 12:05 ET
Flora Growth Announces Pricing of $30 Million Public Offering
2021-11-15 12:05 ET
Flora Growth Completes Acquisition of Vessel Brand Inc.
2021-11-03 11:05 ET
Flora Growth Signs Definitive Agreement to Acquire Vessel Brand, Entering US Cannabis Consumer Technology Market & Strengthening Management Team
2021-10-28 11:05 ET
Flora Beauty to Launch MIND Naturals and Awe (Ô) CBD Skincare Brands with GlossWire
2021-10-27 11:05 ET
Flora Beauty to launch MIND Naturals and Awe (Ô) CBD Skincare Brands at SHOWFIELDS
2021-10-25 11:05 ET
Flora Growth Receives Good Agricultural and Collection Practices (GACP) Certification, Opening Pathway to Dry Flower Export
2021-10-21 11:00 ET
Flora Growth Launches Cannabis Wellness Brand, Munzhi
2021-10-06 11:05 ET
Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials
2021-10-01 12:30 ET
Flora Growth Corp. (NASDAQ: FLGC) in Prime Position as Colombia Eyes Role as Cannabis Market Leader
2021-09-29 12:30 ET
Flora Growth Corp. (NASDAQ: FLGC) Ideally Positioned as Colombia Makes Cannabis Progress
2021-09-21 11:05 ET
Flora Growth Hosting CEO Fireside Discussion
2021-09-17 20:10 ET
Flora Growth Announces Unaudited Financial Results for the Six Month Period Ended June 30, 2021
2021-09-16 11:05 ET
Flora Growth Signs Letter of Intent to Enter Panama, Applauds Recent Cannabis Law Reforms
2021-09-13 12:30 ET
Flora Beauty’s Mind Naturals Recognized As Trendsetting Brand At Cosmoprof North America
2021-09-09 11:05 ET
DELETED: Flora Growth Expands Distribution, Will Launch Stardog Loungewear On E-Commerce Platform Zulily With Over 5 Million Active Customers
2021-09-08 13:00 ET
Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
2021-09-08 12:30 ET
Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain
2021-09-07 11:05 ET
Flora Growth Receives 2021 Commercial Export Quota of 7,900kg of Psychoactive (THC) Cannabis Flower From Colombian Government
2021-09-03 12:30 ET
Flora Lab Receives GMP Certification For Manufacturing Cosmetic Products Demonstrating Operational Excellence And Enabling Global Export Of Product Portfolio
2021-08-24 12:30 ET
Flora Growth Closes Investment in Hoshi, Provides Clear Expected Pathway To European Distribution
2021-08-24 07:00 ET
Hoshi International Inc., a European Focused Medical Cannabis Company Completes Series A Financing
2021-08-19 20:05 ET
Flora Growth Reports H1 2021 Financial Results and Provides Guidance for H2 Revenue Anticipated Between US$9-11M
2021-08-17 12:30 ET
Flora Growth Signs Agreement To Acquire Industry-Leading Vessel Brand, Entering Luxury Cannabis Consumer Technology Segment
2021-08-13 12:30 ET
Flora Growth Corp. (NASDAQ: FLGC) Eyeing Bonanza after Colombian President Changes Cannabis Law
2021-08-12 11:30 ET
Flora Growth Corp. Applauds Nasdaq Board Diversity Initiative, Appoints Lead Scientific Advisor, Dr. Annabelle Manalo-Morgan, PhD to its Board of Directors
2021-08-11 12:30 ET
Flora Growth Corp. (NASDAQ: FLGC) in Prime Position to Benefit from Colombian Legislative Change
2021-08-10 11:05 ET
Flora Growth Fulfills Initial Purchase Order of Appx. US$1.1M to Largest Colombian Food and Beverage Distributor
2021-08-06 18:30 ET
Flora Growth to Hold First Half 2021 Earnings Call on August 19, 2021 After Market Close
2021-07-29 11:05 ET
Flora Growth Executes International Sales Agreement to Enter Australian Medical Cannabis and Over-The-Counter CBD Market
2021-07-27 11:05 ET
Flora Growth to Partner with Avaria to Distribute Award-Winning Pain Cream Brand KaLaya Across LATAM & Produce Its CBD Formulations
2021-07-26 12:00 ET
Argus Research Initiates Equity Research Report Coverage on Flora Growth Corp. (NASDAQ: FLGC)
2021-07-26 11:05 ET
Flora Growth Applauds Update to Colombian Cannabis Regulations that Substantially Increases Revenue Potential; Executes International Cannabis Supply Agreement
2021-07-22 21:41 ET
Flora Growth Announces Warrant Extensions
2021-07-22 11:30 ET
Flora Growth Announces Corporate Headquarters Relocation
2021-07-20 11:30 ET
Flora Beauty Launches Ô (“Awe”) Premium Beauty Brand and Product Line
2021-07-15 12:03 ET
Flora Growth Hosting CEO Fireside Discussion with CRO, Jason Warnock, and Lead Scientific Advisor, Dr. Annabelle Manalo-Morgan
2021-07-12 11:30 ET
 Flora Growth Expands its Food and Beverage Division, Signs Sales Agreement with Largest Colombian Distributor Representing Up to US$10 Million in Expected Annual Sales  
2021-07-08 13:40 ET
Flora Growth Engages Brigitte Baptiste As Strategic Advisor And Enters Into Cooperative Agreement With EAN University
2021-06-29 11:30 ET
Flora Growth Establishes Long-Term Commitment to Environmental and Economic Sustainability
2021-06-23 11:30 ET
Flora Growth Hosting CEO Fireside Discussion on Flora’s International Expansion
2021-06-17 11:30 ET
Flora Growth Appoints Dr. Annabelle Manalo-Morgan, PhD, as Lead Scientific Advisor and Forms Science Advisory Team
2021-06-14 11:30 ET
Flora Growth to Acquire Koch & Gsell and Enter Europe with Leading Manufacturer of Natural Swiss Hemp Products
2021-06-09 11:30 ET
Flora Growth Bolsters Executive Leadership with Strategic New Hires
2021-06-07 11:30 ET
Flora Expands Presence into EU; Signs LOI to Become Long-Term Strategic Partner to Hoshi International
2021-05-26 21:41 ET
Flora Growth Hosting CEO Fireside Discussion Tomorrow
2021-05-25 12:45 ET
Flora Growth Corp. Announces Appointment of Marc Mastronardi to Board of Directors
2021-05-20 11:00 ET
Flora Growth to Ring NASDAQ Closing Bell
2021-05-19 11:00 ET
Flora Growth Forms Flora Lab Manufacturing Division Around Recently Acquired GMP-Certified Laboratory
2021-05-17 11:00 ET
Flora Growth’s Commercial Cultivation Progress Enables 2021 THC and CBD Export to International Markets
2021-05-14 11:00 ET
Flora Growth Expands into U.K. and Central American Markets with Sales to New International Distribution Partners
2021-05-13 21:13 ET
Flora Growth Corp. Announces Closing of Initial Public Offering

SEC forms

Show financial reports only

SEC form 10
2024-03-28 00:00 ET
Flora Growth Corp. reported for 2023 q4
SEC form 10
2023-11-08 00:00 ET
Flora Growth Corp. reported for 2023 q3
SEC form 10
2023-08-10 16:01 ET
Flora Growth Corp. reported for 2023 q2
SEC form 6
2023-08-10 16:01 ET
Flora Growth Corp. published news for 2023 q2
SEC form 10
2023-08-10 00:00 ET
Flora Growth Corp. reported for 2023 q2
SEC form 8
2023-08-10 00:00 ET
Flora Growth Corp. published news for 2023 q2
SEC form 6
2023-07-25 16:31 ET
Flora Growth Corp. published news for 2023 q2
SEC form 6
2023-07-11 17:27 ET
Flora Growth Corp. published news for 2023 q2
SEC form 6
2023-06-27 16:15 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-06-16 16:05 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-06-16 16:05 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-05-15 16:27 ET
Flora Growth Corp. reported for 2023 q1
SEC form 10
2023-05-15 16:25 ET
Flora Growth Corp. reported for 2023 q1
SEC form 8
2023-05-15 00:00 ET
Flora Growth Corp. reported for 2023 q1
SEC form 10
2023-05-15 00:00 ET
Flora Growth Corp. reported for 2023 q1
SEC form 6
2023-05-10 16:45 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-05-01 07:39 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-04-28 16:05 ET
Flora Growth Corp. published news for 2023 q1
SEC form 6
2023-04-18 16:10 ET
Flora Growth Corp. published news for 2023 q1
SEC form 10
2023-03-31 16:16 ET
Flora Growth Corp. reported for 2022 q4
SEC form 6
2023-03-31 16:06 ET
Flora Growth Corp. reported for 2022 q4
SEC form 10
2023-03-31 00:00 ET
Flora Growth Corp. reported for 2022 q4
SEC form 8
2023-03-31 00:00 ET
Flora Growth Corp. reported for 2022 q4
SEC form 6
2023-01-30 08:15 ET
Flora Growth Corp. published news for 2022 q4
SEC form 6
2023-01-06 16:30 ET
Flora Growth Corp. published news for 2022 q4
SEC form 6
2022-12-27 08:00 ET
Flora Growth Corp. published news for 2022 q3
SEC form 6
2022-12-13 16:05 ET
Flora Growth Corp. published news for 2022 q3
SEC form 6
2022-11-28 08:01 ET
Flora Growth Corp. reported for 2022 q3
SEC form 6
2022-10-24 08:00 ET
Flora Growth Corp. published news for 2022 q3
SEC form 6
2022-09-19 06:23 ET
Flora Growth Corp. reported for 2022 q2
SEC form 6
2022-09-16 17:29 ET
Flora Growth Corp. published news for 2022 q2
SEC form 6
2022-08-15 16:19 ET
Flora Growth Corp. reported for 2022 q2
SEC form 6
2022-07-14 08:00 ET
Flora Growth Corp. published news for 2022 q2
SEC form 6
2022-07-11 08:00 ET
Flora Growth Corp. published news for 2022 q2
SEC form 6
2022-07-06 08:00 ET
Flora Growth Corp. published news for 2022 q2
SEC form 6
2022-07-01 08:00 ET
Flora Growth Corp. published news for 2022 q2
SEC form 6
2022-06-16 08:00 ET
Flora Growth Corp. published news for 2022 q1
SEC form 6
2022-06-06 08:00 ET
Flora Growth Corp. published news for 2022 q1
SEC form 6
2022-05-10 07:05 ET
Flora Growth Corp. published news for 2022 q1
SEC form 6
2022-05-09 16:07 ET
Flora Growth Corp. published news for 2022 q1
SEC form 6
2022-04-29 16:11 ET
Flora Growth Corp. published news for 2022 q1
SEC form 6
2022-03-17 08:43 ET
Flora Growth Corp. published news for 2021 q4
SEC form 6
2022-02-28 08:56 ET
Flora Growth Corp. published news for 2021 q4
SEC form 6
2021-11-23 18:28 ET
Flora Growth Corp. published news for 2021 q3
SEC form 6
2021-11-19 16:59 ET
Flora Growth Corp. published news for 2021 q3
SEC form 6
2021-11-15 16:01 ET
Flora Growth Corp. published news for 2021 q3
SEC form 6
2021-09-17 16:26 ET
Flora Growth Corp. published news for 2021 q2
SEC form 6
2021-08-20 13:45 ET
Flora Growth Corp. published news for 2021 q2
SEC form 6
2021-08-12 18:35 ET
Flora Growth Corp. published news for 2021 q2
SEC form 6
2021-07-23 18:30 ET
Flora Growth Corp. published news for 2021 q2
SEC form 6
2021-06-10 10:28 ET
Flora Growth Corp. published news for 2021 q1
SEC form 6
2021-05-25 17:05 ET
Flora Growth Corp. published news for 2021 q1
SEC form 6
2021-05-13 17:20 ET
Flora Growth Corp. published news for 2021 q1
SEC form 6
2021-05-11 09:16 ET
Flora Growth Corp. published news for 2021 q1
SEC form 6
2021-04-29 17:18 ET
Flora Growth Corp. published news for 2021 q1
SEC form 6
2020-12-23 18:23 ET
Flora Growth Corp. published news for 2020 q3
SEC form 6
2020-12-22 17:15 ET
Flora Growth Corp. published news for 2020 q3
SEC form 6
2020-11-10 13:24 ET
Flora Growth Corp. published news for 2020 q3

SEDAR forms

Show financial reports only

SEDAR form
2023-05-15
FLGC published news for 2023 q2
SEDAR form
2023-03-31
FLGC published news for 2023 q1
SEDAR form
2023-03-31
FLGC published news for 2023 q1
SEDAR form
2022-12-28
FLGC published news for 2022 q4